biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Woohoo! another 9 more cents and I can sell at a 75% loss!

<< Previous

Bullboard Posts

Next >>

Comment by beenthereon Jul 31, 2023 10:02am

104 Views

Post# 35564565

RE:RE:RE:Woohoo! another 9 more cents and I can sell at a 75% loss!

Tell me more!

For starters what does BK stand for? Bankrupt?

How can you write it off?

I always thought that capital losses always had to be used against capital gains

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale